
Virtual Visits Market - Global Outlook and Forecast 2022-2027
Description
Virtual Visits Market - Global Outlook and Forecast 2022-2027
The global virtual visits market is expected to grow at a CAGR of 27.15% during 2022-2027.
In the virtual visit, a patient or medical professional uses a computer, smartphone, or tablet to obtain a diagnosis and send a prescription to their pharmacy. The visit is completed without leaving home or the workplace and amounts to far less than the cost of an emergency room or primary care office visit. Virtual visits are available to Health Action Council members and their employees from various vendors and providers. With the increasing telehealth utilization, there is also an increase in the adoption of virtual visit platforms. From 2017 to 2019, the virtual visit doubled for Health Action Council members.
Virtual care offers an easier, faster way to find and see a provider. Less than 2% of outpatient behavioral health and medical claims have been for virtual visits. According to CDC reports, virtual care has seen a 50% increase in March 2020 and continued to increase as lockdowns continued worldwide. According to studies, about 54% of respondents prefer to use virtual health as an option for consultation or diagnosis.
Throughout the COVID-19 pandemic, people have shifted to virtual care for medical and behavioral care because of convenience, ease of schedule, and have been found safe to avoid crowded waiting rooms. A recent report shows that about 76% of people are interested in using telehealth. Even after the pandemic ends, it is expected that about 83% of patients will use virtual care.
The following factors are likely to contribute to the virtual care market growth during the forecast period:
The rising incidences of chronic medical conditions such as diabetes and hypertension influence market growth. Virtual care is a valuable tool for continuous monitoring of chronic diseases and treatment. The adoption of virtual visit services is expected to rise with advancements in technology and high penetration of internet connectivity with more incredible speed & smart gadgets. Communication technologies (ICTs) and Modern information, such as computers, laptops, the Internet, and smartphones, are revolutionizing the communication among people that seek and exchange information and enriching their lives.
Artificial intelligence (AI) will add value and promote the virtual visit market growth. Artificial Intelligence paired with telehealth had been on the rise before the COVID-19, which created increased virtual visits capacity.
VENDORS' ACTIVITIES IN THE MARKET
The global virtual care market is highly dynamic and fragmented, with the presence of several international, regional, and local players. The key players in the market are AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health.
Before the COVID-19 pandemic, the adoption of virtual visits remained low due to a lack of reimbursement, awareness, and internet connectivity. Also, there was a limited number of healthcare providers offering virtual visit services to medical professionals and patients. Telehealth had been around for years before the COVID-19 crisis; there are many regulatory bodies and state parity laws that limited reimbursement by Medicare, Medicaid, and private insurers, curbed allowable sites of care, and placed licensure restrictions on who can provide telehealth services.
Virtual visit services have increased during the COVID-19 pandemic worldwide; the government is permitted to make consultations via virtual visit platforms by relaxing the regulations and increasing reimbursements.
With the surge in COVID-19 cases, the virtual care market jumped from 30% in 2020 to 33% in 2021, while satisfaction with asynchronous telehealth services leveraging pictures and videos grew from 41% to 54% in the same period. In 2020, 53% of US patients said they were more satisfied with live video than with previous in-person interactions.
MARKET SEGMENT ANALYSIS
The service segment is the fastest-growing segment by component, with the highest revenue of USD 10.35 billion in 2021, whereas hardware and software generated $2.91 billion. Several vendors offer a wide range of services in various specialties. The healthcare providers provide services giving both the options of a scheduled or on-demand visit. The services have widely been adopted in high-income countries and are also expected to gain momentum in low-and-middle-income countries. The hardware and software segment is expected to grow at an excellent pace in the forecast period, with a CAGR of 26.20%.
General consultation is the fastest-growing segment, with a CAGR of 25.90%. There were full restrictions worldwide to go outside, and fear of getting COVID-19 infection within hospitals led to increased virtual visits worldwide. The chronic care management market is expected to grow due to the increasing prevalence of chronic diseases and the increasing elderly population. Chronic care management services also give cost-benefit as most of the service fee is cut to as low as $0, depending on the patient's insurance plan, thus saving the overall visit cost. Also, initiatives are increasing support for chronic care management virtual visit services.
Adults are the fastest-growing patient group because of their increasing use of virtual visits. The high population and increasing chronic diseases among adults, especially in the geriatric population, have increased the demand for virtual visits. The use of virtual visit platforms and services is very high among adults from high-income countries with good infrastructure, good internet access, and awareness. The pediatric group is expected to grow at a CAGR of 23.85% during the forecast period.
Segmentation by Component:
North America and Europe have the highest adoption rate of telehealth services due to high internet connectivity, increasing reimbursements, and full insurance coverage. In addition, North America dominates the critical vendor's presence. APAC, Latin America, and the Middle East & Africa region witnessed an increase in the adoption during a pandemic. However, limited reimbursement coverage, data security, privacy concern, lack of infrastructure, and a lack of consumer awareness of telehealth services are hindering the growth of the virtual visits market in these regions.
Segmentation by Geography
1. HOW BIG IS THE GLOBAL VIRTUAL VISITS MARKET?
2. WHAT IS THE GROWTH RATE OF THE GLOBAL VIRTUAL VISITS MARKET?
3. WHO ARE THE LEADING PLAYERS IN THE GLOBAL VIRTUAL VISITS MARKET?
4. WHICH REGION HAS THE HIGHEST NUMBER OF VIRTUAL VISITS SERVICE PROVIDERS?
5. WHAT IS THE GROWTH RATE OF THE HARDWARE AND SOFTWARE SEGMENT OF THE GLOBAL VIRTUAL VISITS MARKET?
The global virtual visits market is expected to grow at a CAGR of 27.15% during 2022-2027.
In the virtual visit, a patient or medical professional uses a computer, smartphone, or tablet to obtain a diagnosis and send a prescription to their pharmacy. The visit is completed without leaving home or the workplace and amounts to far less than the cost of an emergency room or primary care office visit. Virtual visits are available to Health Action Council members and their employees from various vendors and providers. With the increasing telehealth utilization, there is also an increase in the adoption of virtual visit platforms. From 2017 to 2019, the virtual visit doubled for Health Action Council members.
Virtual care offers an easier, faster way to find and see a provider. Less than 2% of outpatient behavioral health and medical claims have been for virtual visits. According to CDC reports, virtual care has seen a 50% increase in March 2020 and continued to increase as lockdowns continued worldwide. According to studies, about 54% of respondents prefer to use virtual health as an option for consultation or diagnosis.
Throughout the COVID-19 pandemic, people have shifted to virtual care for medical and behavioral care because of convenience, ease of schedule, and have been found safe to avoid crowded waiting rooms. A recent report shows that about 76% of people are interested in using telehealth. Even after the pandemic ends, it is expected that about 83% of patients will use virtual care.
The following factors are likely to contribute to the virtual care market growth during the forecast period:
- Rising reimbursements by insurers and the government during the COVID-19 pandemic
- Rising adoption of patient care technology and growing digitalization
- Increasing demand for personalized care in remote areas
- Increasing Prevalence of chronic diseases and aging population
- Reduced waiting time
- It saves the traveling time
- Easy access to expertise and specialty physicians
- Reduces overall cost of healthcare and treatment
- Better disease management
The rising incidences of chronic medical conditions such as diabetes and hypertension influence market growth. Virtual care is a valuable tool for continuous monitoring of chronic diseases and treatment. The adoption of virtual visit services is expected to rise with advancements in technology and high penetration of internet connectivity with more incredible speed & smart gadgets. Communication technologies (ICTs) and Modern information, such as computers, laptops, the Internet, and smartphones, are revolutionizing the communication among people that seek and exchange information and enriching their lives.
Artificial intelligence (AI) will add value and promote the virtual visit market growth. Artificial Intelligence paired with telehealth had been on the rise before the COVID-19, which created increased virtual visits capacity.
VENDORS' ACTIVITIES IN THE MARKET
The global virtual care market is highly dynamic and fragmented, with the presence of several international, regional, and local players. The key players in the market are AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health.
- Expansion activities (facility expansions and regional business) are helping players strengthen their market share and global distribution networks, thus allowing them to explore untapped opportunities.
- Large-scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms
- Forging partnerships and collaborations with well-established manufacturers cementing the footprints of the players
- Active mergers and acquisitions play a vital role in the smooth functioning of the growth cycle.
- The market is experiencing a surge in technological advancements in virtual care and the launch of new software and integrated hardware or devices or connected healthcare devices.
- Vendors invest highly in integrating hardware or connected devices, software, and applications.
- Key vendors operating in the market have demonstrated that they can provide reliable healthcare platforms to a large pool of patients at low cost or even zero cost per visit with the qualifying insurance plan in the US, depending on the type of visit.
- Some key vendors offer services 24/7 in urgent care and provide on-demand video visits.
- Many start-up companies are entering the market with the increased funding being received by the government and the private entities with innovative virtual visits platforms and solutions to gain traction among end-users
- The key players make substantial R&D investments and develop innovative and technologically advanced products, thereby restricting small and medium-sized vendors from capturing higher market shares.
- AMD Global Telemedicine
- American Well
- Koninklijke Philips
- Teladoc Health
- Banner Health
- Beato
- Blue Sky MD
- Careclix
- Cerner
- CHI Health
- Chiron Health
- CVS Health
- Dialogue
- Doctor On Demand
- Doxy(.) ME
- Eagle Telemedicine
- Edgemed Healthcare
- eVisit
- HealthTap
- Health at Hand
- HealthHero
- Instapract
- MDLive
- MediBuddy
- MFine
- NeuroSynaptic Communications
- Nextcare
- Optum
- Plushcare
- Piedmont Healthcare
- Practo
- RO
- Reecuro Health
- SteadyMD
- SOC Telemed
- TRUDOC Healthcare
- Vidyo
- VSee
- Walmart Health Virtual Care
- Zipnosis
- Rising reimbursements by insurers and the government during the COVID-19 pandemic
- Rising adoption of patient care technology and growing digitalization
- Increasing demand for personalized care in remote areas
- Increasing Prevalence of chronic diseases and aging population
Before the COVID-19 pandemic, the adoption of virtual visits remained low due to a lack of reimbursement, awareness, and internet connectivity. Also, there was a limited number of healthcare providers offering virtual visit services to medical professionals and patients. Telehealth had been around for years before the COVID-19 crisis; there are many regulatory bodies and state parity laws that limited reimbursement by Medicare, Medicaid, and private insurers, curbed allowable sites of care, and placed licensure restrictions on who can provide telehealth services.
Virtual visit services have increased during the COVID-19 pandemic worldwide; the government is permitted to make consultations via virtual visit platforms by relaxing the regulations and increasing reimbursements.
With the surge in COVID-19 cases, the virtual care market jumped from 30% in 2020 to 33% in 2021, while satisfaction with asynchronous telehealth services leveraging pictures and videos grew from 41% to 54% in the same period. In 2020, 53% of US patients said they were more satisfied with live video than with previous in-person interactions.
MARKET SEGMENT ANALYSIS
The service segment is the fastest-growing segment by component, with the highest revenue of USD 10.35 billion in 2021, whereas hardware and software generated $2.91 billion. Several vendors offer a wide range of services in various specialties. The healthcare providers provide services giving both the options of a scheduled or on-demand visit. The services have widely been adopted in high-income countries and are also expected to gain momentum in low-and-middle-income countries. The hardware and software segment is expected to grow at an excellent pace in the forecast period, with a CAGR of 26.20%.
General consultation is the fastest-growing segment, with a CAGR of 25.90%. There were full restrictions worldwide to go outside, and fear of getting COVID-19 infection within hospitals led to increased virtual visits worldwide. The chronic care management market is expected to grow due to the increasing prevalence of chronic diseases and the increasing elderly population. Chronic care management services also give cost-benefit as most of the service fee is cut to as low as $0, depending on the patient's insurance plan, thus saving the overall visit cost. Also, initiatives are increasing support for chronic care management virtual visit services.
Adults are the fastest-growing patient group because of their increasing use of virtual visits. The high population and increasing chronic diseases among adults, especially in the geriatric population, have increased the demand for virtual visits. The use of virtual visit platforms and services is very high among adults from high-income countries with good infrastructure, good internet access, and awareness. The pediatric group is expected to grow at a CAGR of 23.85% during the forecast period.
Segmentation by Component:
- Service
- Hardware
- General Consultation
- Behavioral Health
- Chronic Care Management
- Urgent Care
- Others
- Adults
- Paediatric
North America and Europe have the highest adoption rate of telehealth services due to high internet connectivity, increasing reimbursements, and full insurance coverage. In addition, North America dominates the critical vendor's presence. APAC, Latin America, and the Middle East & Africa region witnessed an increase in the adoption during a pandemic. However, limited reimbursement coverage, data security, privacy concern, lack of infrastructure, and a lack of consumer awareness of telehealth services are hindering the growth of the virtual visits market in these regions.
Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- France
- Germany
- Italy
- Spain
- APAC
- Japan
- China
- Australia
- South Korea
- India
- Latin America
- Brazil
- Mexico
- Argentina
- The Middle East and Africa
- Turkey
- UAE
- South Africa
1. HOW BIG IS THE GLOBAL VIRTUAL VISITS MARKET?
2. WHAT IS THE GROWTH RATE OF THE GLOBAL VIRTUAL VISITS MARKET?
3. WHO ARE THE LEADING PLAYERS IN THE GLOBAL VIRTUAL VISITS MARKET?
4. WHICH REGION HAS THE HIGHEST NUMBER OF VIRTUAL VISITS SERVICE PROVIDERS?
5. WHAT IS THE GROWTH RATE OF THE HARDWARE AND SOFTWARE SEGMENT OF THE GLOBAL VIRTUAL VISITS MARKET?
Table of Contents
297 Pages
- 1 RESEARCH METHODOLOGY
- 2 RESEARCH OBJECTIVES
- 3 RESEARCH PROCESS
- 4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY COMPONENT
- 4.3.2 MARKET SEGMENTATION BY APPLICATION
- 4.3.3 MARKET SEGMENTATION BY PATIENT GROUP
- 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
- 5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
- 6 MARKET AT A GLANCE
- 7 INTRODUCTION
- 7.1 OVERVIEW
- 8 PREMIUM INSIGHTS
- 8.1 OVERVIEW
- 8.1.1 VENDOR ACTIVITIES IN THE MARKET
- 8.1.2 FACTORS CONTRIBUTING TO MARKET GROWTH
- 8.1.3 IMPACT OF COVID-19 PANDEMIC
- 8.1.4 MARKET ANALYSIS BY SEGMENTATION
- 9 MARKET OPPORTUNITIES & TRENDS
- 9.1 EMERGING SMART INTEGRATED DEVICES
- 9.2 INCREASING GROWTH OF VIRTUAL VISITS ACTIVITIES
- 9.3 INCREASING STRATEGIC PARTNERSHIPS & MERGERS/ACQUISITIONS
- 10 MARKET GROWTH ENABLERS
- 10.1 HIGHER REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS
- 10.2 LARGER TARGET POOL OF PATIENTS REQUIRING VIRTUAL VISITS
- 10.3 RISE OF VIRTUAL HOSPITALS
- 11 MARKET RESTRAINTS
- 11.1 LACK OF ACCESS TO FIXED INTERNET SERVICE
- 11.2 LEGAL BARRIERS & LACK OF STANDARD REGULATIONS FOR VIRTUAL VISITS
- 11.3 DATA SECURITY AND PRIVACY RISKS
- 12 MARKET LANDSCAPE
- 12.1 MARKET OVERVIEW
- 12.2 MARKET SIZE & FORECAST
- 12.2.1 COMPONENT
- 12.2.2 APPLICATION
- 12.2.3 PATIENT GROUP
- 12.2.4 GEOGRAPHY
- 12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY
- 13 COMPONENT
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 SERVICE
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
- 13.4 HARDWARE & SOFTWARE
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
- 14 APPLICATION
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 GENERAL CONSULTATION
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.4 BEHAVIORAL HEALTH
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
- 14.5 CHRONIC CARE MANAGEMENT
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY
- 14.6 URGENT CARE
- 14.6.1 MARKET OVERVIEW
- 14.6.2 MARKET SIZE & FORECAST
- 14.6.3 MARKET BY GEOGRAPHY
- 14.7 OTHERS
- 14.7.1 MARKET OVERVIEW
- 14.7.2 MARKET SIZE & FORECAST
- 14.7.3 MARKET BY GEOGRAPHY
- 15 PATIENT GROUP
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 MARKET OVERVIEW
- 15.3 ADULTS
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 MARKET BY GEOGRAPHY
- 15.4 PEDIATRIC
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 MARKET BY GEOGRAPHY
- 16 GEOGRAPHY
- 16.1 MARKET SNAPSHOT & GROWTH ENGINE
- 16.2 GEOGRAPHIC OVERVIEW
- 17 NORTH AMERICA
- 17.1 MARKET OVERVIEW
- 17.2 MARKET SIZE & FORECAST
- 17.3 NORTH AMERICA: COMPONENT
- 17.4 NORTH AMERICA: APPLICATION
- 17.5 NORTH AMERICA: PATIENT GROUP
- 17.6 KEY COUNTRIES
- 17.6.1 US: MARKET SIZE & FORECAST
- 17.6.2 CANADA: MARKET SIZE & FORECAST
- 18 EUROPE
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 EUROPE: COMPONENT
- 18.4 EUROPE: APPLICATION
- 18.5 EUROPE: PATIENT GROUP
- 18.6 KEY COUNTRIES
- 18.6.1 UK: MARKET SIZE & FORECAST
- 18.6.2 FRANCE: MARKET SIZE & FORECAST
- 18.6.3 GERMANY: MARKET SIZE & FORECAST
- 18.6.4 ITALY: MARKET SIZE & FORECAST
- 18.6.5 SPAIN: MARKET SIZE & FORECAST
- 19 APAC
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 APAC: COMPONENT
- 19.4 APAC: APPLICATION
- 19.5 APAC: PATIENT GROUP
- 19.6 KEY COUNTRIES
- 19.6.1 JAPAN: MARKET SIZE & FORECAST
- 19.6.2 CHINA: MARKET SIZE & FORECAST
- 19.6.3 AUSTRALIA: MARKET SIZE & FORECAST
- 19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 19.6.5 INDIA: MARKET SIZE & FORECAST
- 20 LATIN AMERICA
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 LATIN AMERICA: COMPONENT
- 20.4 LATIN AMERICA: APPLICATION
- 20.5 LATIN AMERICA: PATIENT GROUP
- 20.6 KEY COUNTRIES
- 20.6.1 BRAZIL: MARKET SIZE & FORECAST
- 20.6.2 MEXICO: MARKET SIZE & FORECAST
- 20.6.3 ARGENTINA: MARKET SIZE & FORECAST
- 21 MIDDLE EAST & AFRICA
- 21.1 MARKET OVERVIEW
- 21.2 MARKET SIZE & FORECAST
- 21.3 MIDDLE EAST & AFRICA: COMPONENT
- 21.4 MIDDLE EAST & AFRICA: APPLICATION
- 21.5 MIDDLE EAST & AFRICA: PATIENT GROUP
- 21.6 KEY COUNTRIES
- 21.6.1 TURKEY: MARKET SIZE & FORECAST
- 21.6.2 UAE: MARKET SIZE & FORECAST
- 21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
- 22 COMPETITIVE LANDSCAPE
- 22.1 COMPETITION OVERVIEW
- 22.2 MARKET SHARE ANALYSIS
- 22.2.1 AMD GLOBAL TELEMEDICINE
- 22.2.2 AMERICAN WELL
- 22.2.3 KONINKLIJKE PHILIPS
- 22.2.4 TELADOC HEALTH
- 23 KEY COMPANY PROFILES
- 23.1 AMD GLOBAL TELEMEDICINE
- 23.1.1 BUSINESS OVERVIEW
- 23.1.1 PRODUCT OFFERINGS
- 23.1.2 KEY STRATEGIES
- 23.1.3 KEY STRENGTHS
- 23.1.4 KEY OPPORTUNITIES
- 23.2 AMERICAN WELL
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
- 23.2.3 KEY STRATEGIES
- 23.2.4 KEY STRENGTHS
- 23.2.5 KEY OPPORTUNITIES
- 23.3 KONINKLIJKE PHILIPS
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
- 23.3.3 KEY STRATEGIES
- 23.3.4 KEY STRENGTHS
- 23.3.5 KEY OPPORTUNITIES
- 23.4 TELADOC HEALTH
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 PRODUCT OFFERINGS
- 23.4.3 KEY STRATEGIES
- 23.4.4 KEY STRENGTHS
- 23.4.5 KEY OPPORTUNITIES
- 24 OTHER PROMINENT VENDORS
- 24.1 BANNER HEALTH
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
- 24.2 BEATO
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
- 24.3 BLUE SKY MD
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
- 24.4 CARECLIX
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
- 24.5 CERNER
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 SERVICE OFFERINGS
- 24.6 CHI HEALTH
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 PRODUCT OFFERINGS
- 24.7 CHIRON HEALTH
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
- 24.8 CVS HEALTH
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 PRODUCT OFFERINGS
- 24.9 DIALOGUE
- 24.9.1 BUSINESS OVERVIEW
- 24.9.2 PRODUCT OFFERINGS
- 24.10 DOCTOR ON DEMAND
- 24.10.1 BUSINESS OVERVIEW
- 24.10.2 PRODUCT OFFERINGS
- 24.11 DOXY.ME
- 24.11.1 BUSINESS OVERVIEW
- 24.11.2 PRODUCT OFFERINGS
- 24.12 EAGLE TELEMEDICINE
- 24.12.1 BUSINESS OVERVIEW
- 24.12.2 PRODUCT OFFERINGS
- 24.13 EDGEMED HEALTHCARE
- 24.13.1 BUSINESS OVERVIEW
- 24.13.2 PRODUCT OFFERINGS
- 24.14 EVISIT
- 24.14.1 BUSINESS OVERVIEW
- 24.14.2 PRODUCT OFFERINGS
- 24.15 HEALTHTAP
- 24.15.1 BUSINESS OVERVIEW
- 24.15.2 PRODUCT OFFERINGS
- 24.16 HEALTH AT HAND
- 24.16.1 BUSINESS OVERVIEW
- 24.16.2 PRODUCT OFFERINGS
- 24.17 HEALTHHERO
- 24.17.1 BUSINESS OVERVIEW
- 24.17.2 PRODUCT OFFERINGS
- 24.18 INSTAPRACT
- 24.18.1 BUSINESS OVERVIEW
- 24.18.2 PRODUCT OFFERINGS
- 24.19 MDLIVE
- 24.19.1 BUSINESS OVERVIEW
- 24.19.2 PRODUCT OFFERINGS
- 24.20 MEDIBUDDY
- 24.20.1 BUSINESS OVERVIEW
- 24.20.2 PRODUCT OFFERINGS
- 24.21 MFINE
- 24.21.1 BUSINESS OVERVIEW
- 24.21.2 PRODUCT OFFERINGS
- 24.22 NEUROSYNAPTIC COMMUNICATIONS
- 24.22.1 BUSINESS OVERVIEW
- 24.22.2 PRODUCT OFFERINGS
- 24.23 NEXTCARE
- 24.23.1 BUSINESS OVERVIEW
- 24.23.2 PRODUCT OFFERINGS
- 24.24 OPTUM
- 24.24.1 BUSINESS OVERVIEW
- 24.24.2 PRODUCT OFFERINGS
- 24.25 PLUSHCARE
- 24.25.1 BUSINESS OVERVIEW
- 24.25.2 PRODUCT OFFERINGS
- 24.26 PIEDMONT HEALTHCARE
- 24.26.1 BUSINESS OVERVIEW
- 24.26.2 PRODUCT OFFERINGS
- 24.27 PRACTO
- 24.27.1 BUSINESS OVERVIEW
- 24.27.2 PRODUCT OFFERINGS
- 24.28 RO
- 24.28.1 BUSINESS OVERVIEW
- 24.28.2 PRODUCT OFFERINGS
- 24.29 REECURO HEALTH
- 24.29.1 BUSINESS OVERVIEW
- 24.29.2 PRODUCT OFFERINGS
- 24.30 STEADYMD
- 24.30.1 BUSINESS OVERVIEW
- 24.30.2 PRODUCT OFFERINGS
- 24.31 SOC TELEMED
- 24.31.1 BUSINESS OVERVIEW
- 24.31.2 PRODUCT OFFERINGS
- 24.32 TRUDOC HEALTH CARE
- 24.32.1 BUSINESS OVERVIEW
- 24.32.2 PRODUCT OFFERINGS
- 24.33 VIDYO
- 24.33.1 BUSINESS OVERVIEW
- 24.33.2 PRODUCT OFFERINGS
- 24.34 VSEE
- 24.34.1 BUSINESS OVERVIEW
- 24.34.2 PRODUCT OFFERINGS
- 24.35 WALMART HEALTH VIRTUAL CARE
- 24.35.1 BUSINESS OVERVIEW
- 24.35.2 PRODUCT OFFERINGS
- 24.36 ZIPNOSIS
- 24.36.1 BUSINESS OVERVIEW
- 24.36.2 PRODUCT OFFERINGS
- 25 REPORT SUMMARY
- 25.1 KEY TAKEAWAYS
- 25.2 STRATEGIC RECOMMENDATIONS
- 26 QUANTITATIVE SUMMARY
- 26.1 MARKET BY GEOGRAPHY
- 26.2 MARKET BY COMPONENT
- 26.3 MARKET BY APPLICATION
- 26.4 MARKET BY PATIENT GROUP
- 26.5 NORTH AMERICA BY COMPONENT
- 26.6 NORTH AMERICA BY APPLICATION
- 26.7 NORTH AMERICA BY PATIENT GROUP
- 26.8 EUROPE BY COMPONENT
- 26.9 EUROPE BY APPLICATION
- 26.10 EUROPE BY PATIENT GROUP
- 26.11 APAC BY COMPONENT
- 26.12 APAC BY APPLICATION
- 26.13 APAC BY PATIENT GROUP
- 26.14 LATIN AMERICA BY COMPONENT
- 26.15 LATIN AMERICA BY APPLICATION
- 26.16 LATIN AMERICA BY PATIENT GROUP
- 26.17 MIDDLE EAST & AFRICA BY COMPONENT
- 26.18 MIDDLE EAST & AFRICA BY APPLICATION
- 26.19 MIDDLE EAST & AFRICA BY PATIENT GROUP
- 27 APPENDIX
- 27.1 ABBREVIATIONS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.